Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
Yi Bao(Stevens Institute of Technology), Arul M. Chinnaiyan(University of Michigan), Ilona Kryczek(University of Michigan), Sara Grove(University of Michigan), Jiali Yu(Cornell University), Yu‐Sun Chang(Chang Gung University), Michael D. Green(University of Pittsburgh), Xuhong Cao(Howard Hughes Medical Institute), Mahnoor Gondal(University of Michigan), Marcin Cieślik(University of Michigan), Rahul Mannan(University of Michigan), Fengyun Su(University of Michigan), Tongchen He(University of Michigan), Weiping Zou(University of Michigan), Yuping Zhang(University of Michigan), Rui Wang(University of Michigan), Yang Zheng(Shanghai Ninth People's Hospital), Caleb Cheng(University of Michigan), Jae Eun Choi(University of Michigan), Gabriel Cruz(Kansas City University), Yuanyuan Qiao(University of Michigan)
Cited by 31
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k